This week, Americans mark 249 years since a group of colonists outraged by a distant government's abuse of power declared their intention to form a new nation. One founded on liberty, equality, and the radical idea at the time that governments derive their powers from the consent of the governed. We celebrate July 4th with fireworks and flags. But the deeper meaning of this day, of this remarkable experiment, is not about triumph. It's about aspiration. The Declaration of Independence certainly did not give ...

Our need to win is turning America into a losing nation, Anne-Marie Slaughter argues. The author of 'The Idea That Is America' explains how the United States lost its moral footing and what it will take to regain it. https://t.co/ACWuGA3Vsa ...

Our need to win is turning America into a losing nation, Anne-Marie Slaughter argues. The author of 'The Idea That Is America' explains how the United States lost its moral footing and what it will take to regain it. https://t.co/WczOQCdmS4 ...

Este es Soy yo, de muy chiquito, nací en la República Independiente de la Boca, una familia laburante, feriantes, la verdad que en un contexto donde había muchísimo amor muy poco dinero. Y a partir de ver la angustia referida a mis viejos, ver cómo trabajaban, ver lo que hacían todos los días, yo ya quería tener kioscos para ayudarlo. Así de chiquito, aunque ustedes no lo crean, yo ya vendía en la calle golosinas para autobastecerme y no pedirle a mis viejos. En ese deseo se forjó algo que claramente yo ten ...

Good afternoon everyone. Let me start with a question. What drives us to define something as right or wrong.Is it our environment. Is it something spiritual. Or does science hold the answer to morality.Today, I'd like to explore how morality stems from the interaction of science and spirituality, the role of truth in our lives, and how our understanding of morality shapes the way that we confront evil. As a woman of science and faith myself, I found it deeply fascinating researching these topics and I am mo ...

SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the pricing of its underwritten public offering of 6,675,000 shares of its common stock at a public offering price of $0.30 per share, for gross proc ...

SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by t ...

Eight Swiss sites are activated in the INVINCIBLE-4 Study, and several patients have been treated European Medicines Agency Authorization to initiate INVINCIBLE-4-Study in FranceSHELTON, Conn., May 13, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition ...

SHELTON, Conn., April 25, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (NASDAQ: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, today announced the pricing of its "reasonable best efforts" public offering with participation from certain new and existing institutional and accredited investors ...